Biovie Inc.
BIVI· Nasdaq
BIVIBiovie Inc.
Filed May 11, 2026 · 10-Q · 41 days after period end · 0001520138-26-000154
| Metric | Q3 2026 | Q3 2025 | Q3 2024 | Q3 2023 |
|---|---|---|---|---|
| Net Income | -$5.27M | -$2.79M | -$8.07M | -$15.04M |
| EPS Diluted | -$0.70 | -$1.51 | -$0.20 | -$0.43 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biovie Inc. · CIK 1580149 · Engraved from SEC EDGAR
ended Mar 31, 2026 · filed May 11, 2026 · 41 d after period end
